Keynote: Francisco Leon - Click here for slides
SESSION 1: IMMUNE MARKERS (Chair: Liping Yu)
Kimber Simmons - Click here for slides
8:40-9:00 The TrialNet T1D at risk registry and cross assay comparative results
Jeffrey Krischer
9:00-9:15 Session 1 Q & A - Click here for video
SESSION 2: MARKERS OF DYSGLYCEMIA & EARLY DIABETES EDUCATION (Chair: Andrea Steck)
9:15-9:35 The value of A1c and OGTT in predicting progression to clinical T1D - Click here for video
Kendra Vehik - Click here for slides
9:35-9:55 The value of CGM in predicting progression to clinical T1D - Click here for video
Andrea Steck - Click here for slides
9:55-10:15 The Early Start Study - Click here for video
Brigitte Frohnert - Click here for slides
10:15-10:30 Session 2 Q & A - Click here for video
SESSION 3: PSYCHOSOCIAL ASPECTS OF SCREENING AND MONITORING (Chair: Judith Baxter)
10:45-11:05 Child/parental anxiety and risk perception - Click here for video
Cristy Geno Rasmussen - Click here for slides
11:05-11:25 Practical strategies to increase engagement - Click here for video
Holly O’Donnell - Click here for slides
11:25-11:45 TEDDY/DAISY/ASK experience - Click here for video
Patricia Gesualdo/ Michelle Hoffman/ Kimberly Bautista - Click here for slides
11:45-12:00 Session 3 Q & A - Click for Video
SESSION 4: REPORTS FROM ONGOING SCREENING PROGRAMS (Chair: Jessica Dunne)
12:30-12:45 Finland - Screening programs for T1D - Click here for video
Riitta Veijola - Click here for slides
12:45-1:00 Sweden -TRIAD- Click here for video
Daniel Agardh - Click here for slides
1:00-1:15 The U.K. – ELSA - Click here for video
Parth Narendran - Click here for slides
1:15-1:30 USA, Virginia – PriMed - Click here for video
Stephen Rich - Click here for slides
1:30-1:45 JDRF T1Detect - Click here for video
Esther Latres - Click here for slides
1:45-2:00 Session 4 Q & A - Click for video
SESSION 5: NEW CHALLENGES (Chair: Aaron Michels)
2:15-2:35 Integration of screening/monitoring with routine care and EHR in PLEDGE - Click here for video
Kurt Griffin - Click here for slides
2:35-3:00 Optimal ages to screen. CASCADE project - Click here for video
William Hagopian/Mohamed Ghalwash - Click here for slides
3:00-3:10 Screening general population adults for islet autoantibodies - Click here for video
Meghan Pauley - Click here for slides
3:10-3:30 Cost-effectiveness of screening - Click here for video
R Brett McQueen - Click here for slides
3:30-3:45 Session 5 Q &A - Click for video
SPECIAL VIRTUAL SESSION: Current Status of General Population Screening Programs
Slides not presented in person during the main program (click to open)
Germany: Fr1da (Anette-Gabriele Ziegler)
USA, Colorado: ASK (Marian Rewers)
USA: ASK the Experts (Kimber Simmons)
Australia: National Screening Pilot (Kirstine Bell)